BLACK BELT THERAPEUTICS
Black Belt Therapeutics focused on translating novel targets in the chronic stress response pathways into new therapeutic approaches to treat cancer
BLACK BELT THERAPEUTICS
Social Links:
Industry:
Biotechnology
Founded:
2018-01-01
Address:
Stevenage, Herefordshire, United Kingdom
Country:
United Kingdom
Total Employee:
1+
Status:
Active
More informations about "Black Belt Therapeutics"
Black Belt Therapeutics - Crunchbase Company Profile & Funding
Organization. Black Belt Therapeutics . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. About. Black Belt Therapeutics focused on translating novel targets …See details»
Black Belt Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials ...
Explore Black Belt Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
CASI Pharmaceuticals in-licenses rights to novel anti …
CASI Pharmaceuticals has announced the signing of a license agreement for exclusive worldwide rights to the investigational anti-CD38 monoclonal antibody (Mab) TSK011010 program from Black Belt Therapeutics. Image: Preclinical …See details»
Black Belt Therapeutics Ltd. - BioCentury Company Profiles - BCIQ
Sep 9, 2021 Black Belt Therapeutics Ltd. - BioCentury Company Profiles for the biopharma industrySee details»
Black Belt Therapeutics - Products, Competitors, Financials, …
Apr 20, 2019 CASI (NSDQ: CASI), a US in-licensing pharma with operations in China, acquired global rights to an investigational anti-CD38 immunotherapy from Black Belt Therapeutics of …See details»
SEC.gov | HOME
In April 2019, the Company entered into a license agreement with Black Belt Therapeutics Limited (“Black Belt”) for exclusive worldwide rights to the investigational anti-CD38 monoclonal …See details»
BLACK BELT THERAPEUTICS LIMITED - Companies House
People for BLACK BELT THERAPEUTICS LIMITED (11550466) More for BLACK BELT THERAPEUTICS LIMITED (11550466) Registered office address 3rd Floor 1 Ashley Road, …See details»
BLACK BELT THERAPEUTICS LIMITED - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for BLACK BELT THERAPEUTICS LIMITED of ALTRINCHAM. Get the latest business insights from Dun & …See details»
Black Belt Therapeutics (Pharmaceutical Antibody License)
Information on acquisition, funding, investors, and executives for Black Belt Therapeutics (Pharmaceutical Antibody License). Use the PitchBook Platform to explore the full profile.See details»
Black Belt Therapeutics Limited - Company Profile - Endole
Sep 4, 2018 Black Belt Therapeutics Limited was registered 6 years ago. Status. ACTIVE. Active since incorporation. Company No. 11550466. Private limited company. Age. 6 years. …See details»
Black Belt Therapeutics - Crunchbase
Organization. Black Belt Therapeutics . Connect to CRM . Save . Summary. People. Signals & News. Similar Companies. Similar Companies. Edit Similar Companies Section. Companies …See details»
Black Belt TX Limited - VentureRadar
Black Belt Therapeutics is a discovery stage immuno oncology company. One Nucleus. Similar Companies: Vesuvius Therapeutics Unknown n/a Vesuvius Therapeutics is a preclinical stage …See details»
Black Belt Therapeutics Ltd innovation strategy - GoodIP
Black Belt Therapeutics Ltd has a total of 26 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, Canada and EPO (European …See details»
Black Belt Therapeutics Limited - Company Profile - Endole
Black Belt Therapeutics Limited is an active company located in Altrincham, Greater Manchester. View Black Belt Therapeutics Limited profile, shareholders, contacts, financials, industry and …See details»
Case Studies — STARBIO INTERNATIONAL
Black Belt Therapeutics. Undertaking: Due diligence. Discovery and validation. After the successful acquisition of Tusk Therapeutics by Roche, Black Belt Therapeutics spined out to …See details»
CID-103 - Drug Targets, Indications, Patents - Synapse
Patients with relapsed/refractory multiple myeloma will be enrolled in a dose-escalation phase receiving monotherapy CID-103. Once the recommended CID-103 dose and infusion duration …See details»
Research programme: cancer therapeutics- Black Belt TX/Praxis …
Small molecule cancer therapeutics jointly developed by Black Belt TX and Praxis Biotech using stress response pathways in the treatment of cancer. Early Research programme: cancer …See details»
Research is a process | Nature Cell Biology
Jun 29, 2022 S.-M.F. has received funding from Bayer AG, Merck, Black Belt Therapeutics and Alesta Therapeutics, has consulted for Fund+ and is in the advisory board of Alesta …See details»
HARBOUR BIOMED SHANGHAI CO LTD innovation strategy - GoodIP
HARBOUR BIOMED SHANGHAI CO LTD has a total of 14 patent applications. Its first patent ever was published in 2018. It filed its patents most often in WIPO (World Intellectual Property …See details»
Cyclone Therapeutics - Crunchbase Company Profile & Funding
Organization. Cyclone Therapeutics . Connect to CRM . Save . Summary. Financials. People. Signals & News. Similar Companies. About "Black belt chemistry" on natural products …See details»